Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Where Gilead Sciences Stands With Analysts
April 29, 2022
Tickers
GILD
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Gilead Sciences (GILD) Q1 2022 Earnings Call Transcript
April 29, 2022
Tickers
GILD
Tags
Recent Press Releases
Market News
GILD
From
Motley Fool
Gilead Sciences Q1 Results Surpass Street Expectation, FY22 Outlook Midpoint Trails Consensus
April 28, 2022
Tickers
GILD
Tags
GILD
Dividends
Guidance
From
Benzinga
Recap: Gilead Sciences Q1 Earnings
April 28, 2022
Tickers
GILD
Tags
Benzinga
Market News
GILD
From
Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
April 28, 2022
Tickers
ABBV
ALNY
AMGN
ANAB
Tags
Briefs
AZN
YMAB
From
Benzinga
Is the S&P 500 All You Need to Retire a Millionaire?
April 28, 2022
Tickers
AAPL
AMZN
BRK-B
CTRA
Tags
GILD
AMZN
AAPL
From
Motley Fool
The Fed may turn investors into stock haters just in time for the next upturn. Boomers may lead the revolt, says this strategist.
April 28, 2022
Tickers
AAPL
AMC
ATER
CAT
Tags
YM00
CENN
EURUSD
From
MarketWatch
CDC study highlights speed with which omicron variant infected Americans, and WHO warns testing is still crucial
April 27, 2022
Tickers
BNTX
GILD
PFE
Tags
GILD
BNTX
PFE
From
MarketWatch
Gilead Sciences's Earnings Outlook
April 27, 2022
Tickers
GILD
Tags
Earnings
GILD
Market News
From
Benzinga
How Gilead is positioning its COVID-19 drug against newer antivirals like Paxlovid
April 27, 2022
Tickers
ABBV
GILD
MRK
PFE
Tags
SPX
ABBV
GILD
From
MarketWatch
3 Things to Know About Amazon Ahead of Its Stock Split
April 27, 2022
Tickers
AMZN
FB
GILD
MSFT
Tags
MSFT
FB
AMZN
From
Motley Fool
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag
April 26, 2022
Tickers
AGRX
AMAM
BGNE
GILD
Tags
BGNE
Health Care
Small Cap
From
Benzinga
Gilead's Remdesivir Becomes First Approved Treatment For Pediatric COVID-19 Patients
April 26, 2022
Tickers
GILD
Tags
Market News
Health Care
News
From
Benzinga
7 Dividend Stocks Paying Over 5% to Buy Now
April 26, 2022
Tickers
DVN
GILD
GM
HMC
Tags
VALE
GILD
MFC
From
InvestorPlace
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?
April 25, 2022
Tickers
ABT
AZN
GILD
GSK
Tags
VIR
GILD
MRK
From
MarketWatch
The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial
April 22, 2022
Tickers
GILD
IBB
NVAX
PFE
Tags
COVID/19 Vaccine
SVRA
Market News
From
Benzinga
WHO Backs Pfizer's Oral COVID Antiviral Therapy For High-Risk Patients
April 22, 2022
Tickers
GILD
PFE
Tags
Briefs
PFE
General
From
Benzinga
Pfizer: What Comes After the Covid-19 Fire?
April 21, 2022
Tickers
BMY
BNTX
CVS
GILD
Tags
PFE
CVS
IBB
From
InvestorPlace
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
April 21, 2022
Tickers
BAYRY
BAYZF
GILD
NVS
Tags
General
BAYRY
News
From
Benzinga
NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy
April 21, 2022
Tickers
GILD
NRXP
Tags
Penny Stocks
General
News
From
Benzinga
If You Invested $1000 In Gilead Sciences 20 Years Ago, Here's How Much You Would Have Today
April 20, 2022
Tickers
GILD
Tags
Market News
News
Benzinga
From
Benzinga
2 Unstoppable Green Flags for AbbVie
April 14, 2022
Tickers
ABBV
AZN
BMY
GILD
Tags
Market News
JNJ
SNY
From
Motley Fool
Why Is Sierra Oncology (SRRA) Stock Up Today?
April 13, 2022
Tickers
ATRS
GILD
GSK
HALO
Tags
Market News
ATRS
NASDAQ:SRRA,NYSE:GSK,NASDAQ:ATRS,NASDAQ:HALO,NASDAQ:GILD
From
InvestorPlace
Why Sierra Oncology Stock Is Soaring Today
April 13, 2022
Tickers
GILD
GSK
SRRA
Tags
Recent Press Releases
Market News
GSK
From
Motley Fool
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
April 12, 2022
Tickers
AGLE
ALPN
ATNM
BDSX
Tags
GILD
CCCC
HOOK
From
Benzinga
FDA Lifts Partial Clinical Hold On Gilead's MDS, AML Magrolimab Studies
April 12, 2022
Tickers
GILD
Tags
Health Care
Market News
acute myeloid leukemia
From
Benzinga
Gilead says FDA lifts partial clinical hold on MDS and AML magrolimab studies
April 11, 2022
Tickers
GILD
Tags
GILD
From
MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
April 11, 2022
Tickers
ANTM
BCRX
FIGS
GILD
Tags
NVO
RCUS
UNH
From
Benzinga
Here's Why a Drop in Moderna's Revenue Wouldn't Be Catastrophic
April 08, 2022
Tickers
ABBV
BMY
GILD
MRK
Tags
Recent Press Releases
MRK
GILD
From
Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Tickers
BIIB
BLUE
GILD
IBB
Tags
NASDAQ:BLUE,NASDAQ:IBB,NYSEARCA:XBI,NASDAQ:MRNA,,NYSE:NVS,NASDAQ:GILD,NYSE:MRK,NASDAQ:BIIB,NYSE:PFE
MRK
MRNA
From
InvestorPlace
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.